Jessica Pegula has pulled out of the WTA 500 Singapore Open, and anyone who watched her US Open semifinal saw this coming.
The tournament, set to start on September 21, loses its highest-profile American entrant just days after Pegula’s flat, subdued exit in New York against Aryna Sabalenka. The scoreline told one story. Her body language told another.
A semifinal that didn’t look like Pegula
Pegula, 32, has built her rise to World No. 3 on clean ball-striking, relentless intensity and a kind of quiet stubbornness in long rallies. None of that really surfaced against Sabalenka.
She moved a half-step slower. The trademark depth on her groundstrokes came and went. The energy that usually crackles off her game felt dulled, as if she were playing with the handbrake on. Some pointed straight to Sabalenka’s power and precision as the reason; the Belarusian can make anyone look rushed and reactive on a big stage.
But this didn’t just look like an opponent overpowering her. It looked like a player not quite at full capacity.
The “mystery bandages” that raised eyebrows
The withdrawal from Singapore slots into a pattern that had already started to nag at observers during the US Open.
Across the second week in New York, Pegula appeared with unexplained bandages in different spots. In the quarterfinals, there was one wrapped around her shin. In the semifinal, another appeared high on her leg, near the quadriceps.
No official explanation followed. No injury announcement. No detailed medical update.
They may prove entirely unrelated to her decision to skip Singapore. Players often manage minor issues quietly, tape up and play on. But the optics were hard to ignore: visible bandaging, a dip in physical spark, then a withdrawal from her next scheduled event.
For a player chasing year-end prizes, that sequence matters.
WTA Finals picture: Pegula still in control
Despite the Singapore setback, Pegula’s season remains on a strong track where it counts most at this stage of the calendar: the WTA Finals race.
She currently sits at World No. 3, in prime position to qualify for the elite eight-player field set for Indian Wells beginning November 8. The margins at the top are always tight, but “in danger” is not the phrase that fits her status right now.
From an American perspective, the stakes are clear. Pegula and Coco Gauff, ranked No. 4, are the only U.S. women currently inside the qualification zone for the WTA Finals. Amanda Anisimova, at World No. 11, waits just outside, needing a late-season surge and some help from those above her.
There is time for movement. A lot of it. Two months of hard-court and indoor tennis can reshape the race quickly, especially if injuries or fatigue creep in for the leaders.
A calculated pause in a crowded season
Pegula’s decision to step away from Singapore, then, feels less like a shock and more like a calculated pause in a brutal stretch of the season. She has already logged heavy miles, carried the pressure of top-three status, and shouldered deep runs at the sport’s biggest events.
If the bandages in New York signaled anything, it was that her body has been absorbing the cost.
With Indian Wells and the WTA Finals looming, this is the moment where top players decide what truly matters. Pegula has made her choice. The question now is whether this reset leaves her fresher and more dangerous when the season’s last, richest stage opens in the California desert.
